TAmiRNA @ GSEV 2025

TAmiRNA Announces Gold Sponsorship of GSEV Autumn Meeting 2025 and Presentation by Matthias Hackl

TAmiRNA, a pioneer in transcriptomics-based biomarker research, is proud to announce its participation as a Gold Sponsor at the GSEV Autumn Meeting 2025, hosted by the German Society for Extracellular Vesicles (GSEV). The annual conference will take place on September 25–26, 2025, at the Audimax of the University Hospital Essen.

As part of the scientific program, Matthias Hackl (TAmiRNA) will deliver a presentation on Thursday, September 25, at 12:15 pm entitled:
“Small RNA-sequencing (miND®) Enables Discovery of EV-specific MicroRNA Signatures to Support EV Therapeutics Development.”

“Using miND®, we can robustly identify EV-specific microRNA signatures – a critical step toward enabling data-driven research and the development of EV-based therapeutics,” said Matthias Hackl, CEO & CSO at TAmiRNA.

TAmiRNA at GSEV 2025 – At a Glance

• Role: Gold Sponsor (TAmiRNA)
• Conference: GSEV Autumn Meeting 2025, September 25–26, 2025, University Hospital Essen, Audimax
• Talk: September 25, 12:15 pm – Matthias Hackl (TAmiRNA): “Small RNA-sequencing (miND®) Enables Discovery of EV-specific MicroRNA Signatures to Support EV Therapeutics Development”
• Posters:
  • “Small RNA-sequencing (miND®) Enables Discovery of EV-specific MicroRNA Signatures to Support EV Therapeutics Development” (Magdalena Mecking)
  • “Preserving the Message: isomiR Landscapes in Cells, EVs, and Protein Complexes” (Matthias Hackl)

We are excited to be part of the GSEV community and look forward seeing you at our Booth to explore how TAmiRNA can elevate your EV research.

We look forward to seeing you in Essen!